ResearcherMayo ClinicActive in the last 2 years
Brennan G. Olson
Matched on ORCID iD 0000-0003-2803-5363; OpenAlex author ID A5040432597; NIH RePORTER profile ID 14815813. Sources: OpenAlex.
Their work
- Papers
- 8 (first author 1, last author 0)
- Trials
- 0
- Grants
- 1
- Labs led
- 0
- Collaborators
- 14
2019: 3 papers · 2020: 2 papers · 2021: 1 paper, 1 grant · 2022: 1 paper · 2023: none · 2024: 1 paper
Papers 8
- GDF15 and LCN2 for early detection and prognosis of pancreatic cancer. First author DOI 10.1016/j.tranon.2024.102129↗
- Critical changes in hypothalamic gene networks in response to pancreatic cancer as found by single-cell RNA sequencing. Co-author DOI 10.1016/j.molmet.2022.101441↗
- Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexia. Co-author DOI 10.1038/s41467-021-22361-3↗
- Microglia in the hypothalamus respond to tumor-derived factors and are protective against cachexia during pancreatic cancer. Co-author DOI 10.1002/glia.23796↗
- Circulating myeloid cells invade the central nervous system to mediate cachexia during pancreatic cancer. Co-author DOI 10.7554/elife.54095↗
- MyD88 signalling is critical in the development of pancreatic cancer cachexia. Co-author DOI 10.1002/jcsm.12377↗
- The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer. Co-author DOI 10.1038/s41467-019-12657-w↗
- Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer. Co-author DOI 10.1038/s41467-019-13151-z↗
Grants 1
Closest collaborators
The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Daniel L. Marks · 8 shared papers, 2019–2024 · strength 0.95
- Paper GDF15 and LCN2 for early detection and prognosis of pancreatic cancer. DOI 10.1016/j.tranon.2024.102129↗
- Paper Critical changes in hypothalamic gene networks in response to pancreatic cancer as found by single-cell RNA sequencing. DOI 10.1016/j.molmet.2022.101441↗
- Paper Microglia in the hypothalamus respond to tumor-derived factors and are protective against cachexia during pancreatic ca… DOI 10.1002/glia.23796↗
- Xinxia Zhu · 7 shared papers, 2019–2024 · strength 0.78
- Paper GDF15 and LCN2 for early detection and prognosis of pancreatic cancer. DOI 10.1016/j.tranon.2024.102129↗
- Paper Microglia in the hypothalamus respond to tumor-derived factors and are protective against cachexia during pancreatic ca… DOI 10.1002/glia.23796↗
- Paper Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexia. DOI 10.1038/s41467-021-22361-3↗
- Kevin G. Burfeind · 6 shared papers, 2019–2021 · strength 0.59
- Paper Microglia in the hypothalamus respond to tumor-derived factors and are protective against cachexia during pancreatic ca… DOI 10.1002/glia.23796↗
- Paper Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexia. DOI 10.1038/s41467-021-22361-3↗
- Paper MyD88 signalling is critical in the development of pancreatic cancer cachexia. DOI 10.1002/jcsm.12377↗
- Katherine A. Michaelis · 6 shared papers, 2019–2021 · strength 0.59
- Paper Microglia in the hypothalamus respond to tumor-derived factors and are protective against cachexia during pancreatic ca… DOI 10.1002/glia.23796↗
- Paper Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexia. DOI 10.1038/s41467-021-22361-3↗
- Paper MyD88 signalling is critical in the development of pancreatic cancer cachexia. DOI 10.1002/jcsm.12377↗
- Christian Huisman · 3 shared papers, 2020–2022 · strength 0.39
- Paper Critical changes in hypothalamic gene networks in response to pancreatic cancer as found by single-cell RNA sequencing. DOI 10.1016/j.molmet.2022.101441↗
- Paper Microglia in the hypothalamus respond to tumor-derived factors and are protective against cachexia during pancreatic ca… DOI 10.1002/glia.23796↗
- Paper Circulating myeloid cells invade the central nervous system to mediate cachexia during pancreatic cancer. DOI 10.7554/elife.54095↗
- Katherine R. Pelz · 4 shared papers, 2019–2021 · strength 0.38
- Paper Lipocalin 2 mediates appetite suppression during pancreatic cancer cachexia. DOI 10.1038/s41467-021-22361-3↗
- Paper MyD88 signalling is critical in the development of pancreatic cancer cachexia. DOI 10.1002/jcsm.12377↗
- Paper The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer. DOI 10.1038/s41467-019-12657-w↗
- Aaron J. Grossberg · 2 shared papers, 2021–2024 · strength 0.30
- Terry K. Morgan · 3 shared papers, 2019 · strength 0.26
- Paper MyD88 signalling is critical in the development of pancreatic cancer cachexia. DOI 10.1002/jcsm.12377↗
- Paper The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer. DOI 10.1038/s41467-019-12657-w↗
- Paper Publisher Correction: The TLR7/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cance… DOI 10.1038/s41467-019-13151-z↗
- Parham Diba · 1 shared paper, 2024 · strength 0.18
- Ariana L. Sattler · 1 shared paper, 2024 · strength 0.18
- Lisa M. Coussens · 2 shared papers, 2019 · strength 0.16
- H. Carlo Maurer · 2 shared papers, 2019 · strength 0.16
- Shannon M. Liudahl · 2 shared papers, 2019 · strength 0.16
- Kenneth P. Olive · 2 shared papers, 2019 · strength 0.16
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.